» Articles » PMID: 8680738

Stereoselective Uptake of Beta-lactam Antibiotics by the Intestinal Peptide Transporter

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1995 Dec 1
PMID 8680738
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

1. The stereoselective transport of beta-lactam antibiotics has been investigated in the human intestinal epithelial cell line, Caco-2, by use of D- and L-enantiomers of cephalexin and loracarbef as substrates. 2. The L-isomers of cephalexin, loracarbef and dipeptides displayed a higher affinity for the oligopeptide/H(+)-symporter in Caco-2 cells than the D-isomers. This was demonstrated by inhibition of the influx of the beta-lactam, [3H]-cefadroxil. 3. By measurement of the substrate-induced intracellular acidification in Caco-2 cells loaded with the pH-sensitive fluorescent dye BCECF (2',7'-bis(2-carboxyethyl)-5-(6)-carboxy-fluorescein), it was demonstrated for the first time that L-isomers of beta-lactams not only bind to the peptide transporter with high affinity but are indeed transported. 4. Efficient proton-coupled transport of L-beta-lactam antibiotics was also shown to occur in Xenopus laevis oocytes expressing the cloned peptide transporter PepT1 from rabbit small intestine. 5. Both cell systems therefore express a stereoselective transport pathway for beta-lactam antibiotics with very similar characteristics and may prove useful for screening rapidly the oral availability of peptide-derived drugs.

Citing Articles

The Role of ABCB1, ABCG2, and SLC Transporters in Pharmacokinetic Parameters of Selected Drugs and Their Involvement in Drug-Drug Interactions.

Kielbowski K, Krol M, Bakinowska E, Pawlik A Membranes (Basel). 2024; 14(11).

PMID: 39590609 PMC: 11596214. DOI: 10.3390/membranes14110223.


Structural basis for antibiotic transport and inhibition in PepT2.

Parker J, Deme J, Lichtinger S, Kuteyi G, Biggin P, Lea S Nat Commun. 2024; 15(1):8755.

PMID: 39384780 PMC: 11464717. DOI: 10.1038/s41467-024-53096-6.


Structural basis for antibiotic transport and inhibition in PepT2, the mammalian proton-coupled peptide transporter.

Newstead S, Parker J, Deme J, Lichtinger S, Kuteyi G, Biggin P Res Sq. 2024; .

PMID: 38903084 PMC: 11188089. DOI: 10.21203/rs.3.rs-4435259/v1.


Molecular Insights to the Structure-Interaction Relationships of Human Proton-Coupled Oligopeptide Transporters (PepTs).

Luo Y, Gao J, Jiang X, Zhu L, Zhou Q, Murray M Pharmaceutics. 2023; 15(10).

PMID: 37896276 PMC: 10609898. DOI: 10.3390/pharmaceutics15102517.


Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.

Schlessinger A, Zatorski N, Hutchinson K, Colas C Trends Biochem Sci. 2023; 48(9):801-814.

PMID: 37355450 PMC: 10525040. DOI: 10.1016/j.tibs.2023.05.011.


References
1.
Tsuji A, Tamai I, Hirooka H, Terasaki T . Beta-lactam antibiotics and transport via the dipeptide carrier system across the intestinal brush-border membrane. Biochem Pharmacol. 1987; 36(4):565-7. DOI: 10.1016/0006-2952(87)90369-8. View

2.
Matthews D . Mechanisms of peptide transport. Beitr Infusionther Klin Ernahr. 1987; 17:6-53. View

3.
Donowitz G, Mandell G . Beta-Lactam antibiotics (1). N Engl J Med. 1988; 318(7):419-26. DOI: 10.1056/NEJM198802183180706. View

4.
Tamai I, Ling H, Timbul S, Nishikido J, Tsuji A . Stereospecific absorption and degradation of cephalexin. J Pharm Pharmacol. 1988; 40(5):320-4. DOI: 10.1111/j.2042-7158.1988.tb05259.x. View

5.
Inui K, Okano T, Maegawa H, Kato M, Takano M, Hori R . H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine. J Pharmacol Exp Ther. 1988; 247(1):235-41. View